Jul 10, 2026 04:05PM
Jun 1, 2026 09:00AM
Jun 1, 2026 09:00AM
May 11, 2026 09:02AM
May 11, 2026 09:00AM
May 7, 2026 04:15PM
Apr 6, 2026 09:00AM Revelation Biosciences forms advisory board for kidney injury trial
Apr 6, 2026 09:00AM
Feb 26, 2026 04:15PM
Jan 26, 2026 09:55AM
Jan 26, 2026 09:55AM
Jan 23, 2026 02:11PM
Jan 23, 2026 02:10PM
Jan 21, 2026 08:31AM Revelation Biosciences reaches FDA agreement on drug approval pathway
Jan 21, 2026 08:30AM
Jan 14, 2026 09:00AM
Jan 7, 2026 09:03AM
Jan 7, 2026 09:00AM
Dec 1, 2025 09:00AM
Nov 20, 2025 09:01AM
Nov 20, 2025 09:00AM Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year
Nov 6, 2025 04:15PM
Oct 29, 2025 09:00AM
Oct 15, 2025 05:00PM
Sep 11, 2025 08:32AM
Sep 11, 2025 08:30AM
Sep 10, 2025 07:23AM
Sep 9, 2025 08:14AM Revelation Biosciences reports positive phase 1b study results for CKD drug
Aug 8, 2025 06:30AM
Jul 24, 2025 09:00AM
Jul 16, 2025 09:00AM
Jul 1, 2025 05:26PM
Jul 1, 2025 05:26PM
May 29, 2025 04:05PM
May 29, 2025 08:01AM Revelation Biosciences (REVB) Prices 3.64M Share Offering at $1.10/sh
May 29, 2025 08:00AM
May 23, 2025 04:07PM
May 23, 2025 04:05PM
May 8, 2025 04:15PM
Apr 29, 2025 09:00AM
Mar 17, 2025 06:00AM
Mar 6, 2025 04:15PM Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024
Feb 26, 2025 06:00AM
Feb 24, 2025 06:00AM
Jan 24, 2025 06:05AM
Jan 24, 2025 06:00AM
Jan 21, 2025 06:00AM
Jan 13, 2025 06:00AM
Jan 6, 2025 06:00AM Nasdaq Grants Revelation Biosciences Inc. Continued Listing
Dec 3, 2024 08:38AM

325,297 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All